相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
C. Ford et al.
MULTIPLE SCLEROSIS (2010)
Rapid disease course in African Americans with multiple sclerosis
I. Kister et al.
NEUROLOGY (2010)
Real-Life Impact of Early Interferonβ Therapy in Relapsing Multiple Sclerosis
M. Trojano et al.
ANNALS OF NEUROLOGY (2009)
Estimating Direct Effects in Cohort and Case-Control Studies
Stijn Vansteelandt
EPIDEMIOLOGY (2009)
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients
M. Debouverie et al.
MULTIPLE SCLEROSIS (2009)
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation
P. J. Veugelers et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Will Rogers Phenomenon in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2008)
The role of cancer registries in cancer control
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
L. Kappos et al.
NEUROLOGY (2006)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
Forward telescoping bias in reported age of onset: an example from cigarette smoking
EO Johnson et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2005)
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
SJ Pittock et al.
NEUROLOGY (2004)
Disease modifying therapies in multiple sclerosis - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
DS Goodin et al.
NEUROLOGY (2002)